Capital International Investors
JUNO

Capital International Investors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Capital International Investors’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,289,358
Closed -$287M – 237
2017
Q4 		$287M Buy
6,289,358
+575,160
+10% +$28.7M 0.32% 98
2017
Q3 		$256M Buy
+5,714,198
New +$195M 0.31% 102

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Capital International Investors's JUNO Position: Q1 2018 in Review

Capital International Investors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 6,289,358 shares — an estimated $287M sold.

Capital International Investors first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $287M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Capital International Investors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Capital International Investors sold 6,289,358 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $287M.
  • Capital International Investors first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Capital International Investors's Juno Therapeutics, Inc. position peaked at $287M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Capital International Investors's 13F filing for Q1 2018, filed 15 May 2018.